A little less than two months after receiving an FDA approval in spinal muscular atrophy, Roche’s Genentech continues to roll out data for risdiplam.
The drug, marketed as Evrysdi in the US, showed improved motor functions in infants as part of a two-y… […]
The FDA’s recent slapdown of Gilead’s rheumatoid arthritis JAK filgotinib didn’t even slightly delay its arrival in 2 big world markets. The EC stamped its marketing authorization on the blockbuster candidate at the end of the week, following the news … […]
Maria Azhunova, winner of the 2020 Bright Award, supports the intergenerational transfer of traditional knowledge and biocultural approaches to nature conservation through her work at the Baikal Buryat Center for Indigenous Cultures. […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new 2-year data from Part 1 of the pivotal FIREFISH study of Evrysdi™ (risdiplam) in infants aged 2-7 months with symptom… […]
SAN FRANCISCO–(BUSINESS WIRE)–Go Safe Labs has released a new national traffic safety study revealing the top ten least safe states for car accidents involving children. […]
Nutcracker looks to crack a big nut by automating a process to efficiently create both patient-specific and broadly applicable RNA medicines, starting in cancer.
Gilead Sciences Inc. will pay $97 million to settle Justice Department claims that the Peninsula drug maker illegally used a foundation to cover the copays of thousands of Medicare patients taking a hypertension drug.
The case is part of an ongoing pu… […]
Researchers found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance. […]
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., senior vice president of translational research, will present at the Stifel Immunology and Inflammatio… […]
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the addition of David J. Woodhouse, Ph.D., to the Board of Directors. D… […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
